David A. Fox

Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial

L. Tsoi, J. Gudjonsson, J. Kahlenberg, 2022 .

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma

D. Khanna, P. Coit, A. Sawalha, 2019, Proceedings of the National Academy of Sciences.